Brief: Akebia Announces Swissmedic Approval Of Vafseo
20/06/2023 13:54
June 20 (Reuters) - Akebia Therapeutics Inc AKBA.O :
* AKEBIA ANNOUNCES SWISSMEDIC APPROVAL OF VAFSEO®
(VADADUSTAT)
Source text for Eikon: ID:nPn5L3JR1a
Further company coverage: AKBA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Akebia Therapeutics
See all newsAkebia Q1 revenue falls, net income misses analyst estimates on higher expenses
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers To Its Board Of Directors
Akebia posts wider-than-expected Q4 net loss as higher expenses hurt
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule